Loading…
This event has ended. Visit the official site or create your own event on Sched.
View analytic
Wednesday, November 1 • 15:00 - 16:30
301 – Moving from lab to market: models of knowledge translation in Canada/ Du laboratoire au marché : modèles de transfert de connaissances au Canada
Panel Organizer: Sean Lee, TRIUMF

Sign up or log in to save this to your schedule and see who's attending!

Feedback form is now closed.
Panel Organizer: Sean Lee, TRIUMF

Moving innovation from the laboratory to the market is not only critical to maintaining Canada’s position as a global scientific leader, but it’s fundamental to our long-term growth and prosperity. This reality is widely recognized across the national science, technology, and innovation landscape, and there are a number of organizations – each with a unique focus and operating model – enjoying successes in this area.
This panel will bring together the leaders of a number of high profile incubator and accelerators from across Canada, representing sectors as diverse as information communication technology, health sciences, and physics. Profiling five case studies, the panel will demonstrate that there is no one-size-fits-all solution for innovation, but rather a mosaic of models, which together can get Canada to where it needs to be vis-à-vis growing global competition.

Moderators
avatar for Karimah Es Sabar

Karimah Es Sabar

CEO and Partner, Quark Venture Inc.
In her role as CEO & Partner at Quark Venture Ms. Es Sabar is also a Director of the Global Health Sciences Fund (GHS Fund), which was co-established with GF Securities Hong Kong and is one of the largest health sciences venture funds. | | Prior to joining Quark Venture, Ms. Es... Read More →

Speakers
avatar for Kathryn Hayashi

Kathryn Hayashi

President & CEO, TRIUMF Innovations Inc.
Prior to TRIUMF Innovations, Ms. Hayashi was the Founding Chief Financial Officer of The Centre for Drug Research and Development (CDRD) and CDRD Ventures Inc, Canada’s national drug development and commercialization engine. As part of the founding team that started CDRD in 2007... Read More →
avatar for Gordon C. McCauley

Gordon C. McCauley

President & CEO, The Centre for Drug Research and Development (CDRD)
Gordon McCauley was appointed President and CEO of The Centre for Drug Research and Development (CDRD) in 2017 after serving on the Board for four years. Mr. McCauley is an accomplished life science investor and executive. | | He has served as President & CEO of Viable Healthworks... Read More →
avatar for Parimal Nathwani

Parimal Nathwani

Vice-President, Life Sciences, MaRS Innovation
Parimal Nathwani has over 15 years of experience in various aspects of the biotechnology industry, including corporate finance, business development, transactions, intellectual property management, technology development and operations. He has been actively involved in forming and... Read More →
avatar for Laura O'Blenis

Laura O'Blenis

Co-Founder and Managing Director, Canadian Association of University Research Parks (AURP)
Laura is the Co-Founder and Managing Director of the Canadian Association of University Research Parks (AURP). As part of work with AURP, Laura spearheaded federal government negotiations for access to national funding by the 26 research and technology parks in Canada, negotiated... Read More →
avatar for Rebecca Yu

Rebecca Yu

Vice President, Market Access & External Affairs, Takeda Canada
Rebecca Yu is the Vice President, Market Access & External Affairs at Takeda Canada. Prior to assuming this role, she held the position of Head, JLABS Canada and was instrumental in setting up J&J Innovation’s first JLABS incubator outside the United States.  She was previously... Read More →


Wednesday November 1, 2017 15:00 - 16:30
ROOM 211 Shaw Centre, 55 Colonel By Dr, Ottawa, ON K1N 9J2

Attendees (26)